tiprankstipranks
Mirum Pharmaceuticals (MIRM)
NASDAQ:MIRM
US Market
MIRM
Mirum Pharmaceuticals
RESEARCH TOOLSreports
Want to see MIRM full AI Analyst Report?

Mirum Pharmaceuticals (MIRM) Stock News & Sentiment

750 Followers
Mirum’s Volixibat Succeeds in Phase 2b PSC Itch Trial
Premium
Company Announcements
Mirum’s Volixibat Succeeds in Phase 2b PSC Itch Trial
2d ago
8K
MIRM
Mirum’s brelovitug succeeds in Phase 2b HDV trial
Premium
Company Announcements
Mirum’s brelovitug succeeds in Phase 2b HDV trial
9d ago
8K
MIRM
Mirum Therapeutics: Favorable Risk/Reward Ahead of Key 2Q26 VISTAS Readout for Volixibat in PSC
Premium
Ratings
Mirum Therapeutics: Favorable Risk/Reward Ahead of Key 2Q26 VISTAS Readout for Volixibat in PSC
1M ago
MIRM
Buy Rating on Mirum Pharmaceuticals Driven by Volixibat’s Differentiated IBAT Profile, Favorable PBC Market Dynamics, and Upside from PSC Expansion
Premium
Ratings
Buy Rating on Mirum Pharmaceuticals Driven by Volixibat’s Differentiated IBAT Profile, Favorable PBC Market Dynamics, and Upside from PSC Expansion
1M ago
MIRM
Mirum Pharmaceuticals: Livmarli-Driven Outperformance and Catalyst-Rich Pipeline Underpin Buy Rating
Premium
Ratings
Mirum Pharmaceuticals: Livmarli-Driven Outperformance and Catalyst-Rich Pipeline Underpin Buy Rating
2M ago
MIRM
Is MIRM a Buy, Before Earnings?
Premium
Pre-Earnings
Is MIRM a Buy, Before Earnings?
2M ago
MIRM
Mirum Pharmaceuticals Completes Bluejay Acquisition, Expands Liver Portfolio
Premium
Company Announcements
Mirum Pharmaceuticals Completes Bluejay Acquisition, Expands Liver Portfolio
3M ago
8K
MIRM
More MIRM News >

MIRM News on the Web

2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term
The Motley Fool
Bullish
Prediction: Buying This Biotech Stock Today Could Set You Up for Life
The Motley Fool
Bullish
Cantor Fitzgerald Sticks to Their Buy Rating for Mirum Pharmaceuticals (MIRM)
TipRanks News
Bullish
ClearBridge SMID Cap Growth Strategy Outperforms with New Positions
GuruFocus News
Neutral
Analysts’ Top Healthcare Picks: ADC Therapeutics (ADCT), Mirum Pharmaceuticals (MIRM)
TipRanks News
Bullish
Mirum (MIRM) Q2 2025 Earnings Call Transcript
The Motley Fool
Neutral
Mirum Pharma (MIRM) Earnings Call Transcript
The Motley Fool
Neutral
Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last?
Zacks
Bullish

News Score - Last 7 Days

Neutral
MIRM
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MIRM’s Media Buzz Sentiment?
1 articles about MIRM were published this week. In an average week, 3.5 articles are published.
    What is MIRM’s weekly average amount of articles?
    In an average week, 3.5 articles about MIRM are published.
      What is MIRM’s News Sentiment?
      100% of articles about MIRM were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week